1. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Guideline for Good Clinical Practice E6(R1). ICH Harmonised Tripartite Guideline. 1996.
2. European Commission. Detailed Guidance on the Collection, Verification, and Presentation of Adverse Reaction Reports Arising from Clinical Trials on Medicinal Products for Human Use. 2006.
3. US Department of Health and Human Services Food and Drug Administration. Safety Reporting Requirements for INDs and BA/BE Studies. Guidance for Industry and Investigators. 2012.
4. Crowe BJ et al. Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team. Clinical Trials 2009; 6: 430–440.
5. Xia HA et al. Planning and core analyses for periodic aggregate safety data reviews. Clinical Trials 2011; 8: 175–182.